Home › Funds › First Light Asset Management, LLC › HCAT

First Light Asset Management, LLC position in HCAT

HEALTH CATALYST INC · Information Technology

First Light Asset Management, LLC reported holding 12,810,861 shares of HCAT (HEALTH CATALYST INC) in its Q2 2026 13F filing — a position valued at US$25.5M, representing 1.55% of its reported portfolio and ranking #22 among its reported holdings. First Light Asset Management, LLC has disclosed HCAT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)12.81M sh
Reported value held$25.49M
Portfolio Weight1.55%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Light Asset Management, LLC's HCAT position evolved

First Light Asset Management, LLC first disclosed a stake in HCAT in Q3 2023 at 2,930,144 shares (US$29.7M). The position peaked in Q1 2025 at 10,436,807 shares, worth US$47.3M. Across 12 filings, First Light Asset Management, LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 12,810,861 shares valued at US$25.5M — a reduction of -67,839 shares quarter over quarter.. Notable position changes include a 65% trim in Q4 2023 (shares fell 19% over the following quarter), a 438% increase in Q2 2024 (shares rose 27% over the following quarter), a 99% increase in Q1 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.93M $29.65M New
Q4 2023 1.01M $9.39M Reduce
Q1 2024 734.68K $5.53M Reduce
Q2 2024 3.96M $25.28M Add
Q3 2024 4.30M $34.97M Add
Q4 2024 5.24M $37.05M Add
Q1 2025 10.44M $47.28M Add
Q2 2025 12.23M $46.11M Add
Q3 2025 13.44M $38.29M Add
Q4 2025 12.91M $30.86M Reduce
Q1 2026 12.88M $16.36M Hold
Q2 2026 12.81M $25.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HCAT and 13F data

HCAT (HEALTH CATALYST INC) is a Information Technology company. 7 other funds we track also report a position in HCAT — the largest reported positions include CDC Financial, Inc. (US$14.1M), Palogic Value Management, L.P. (US$9.8M), Nepsis Inc. (US$5.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HCAT

All HCAT fund holders →

FAQ

How long has First Light Asset Management, LLC held HCAT?

First Light Asset Management, LLC has disclosed HCAT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is First Light Asset Management, LLC's current position in HCAT?

As of Q2 2026, First Light Asset Management, LLC holds 12.81M shares of HCAT (HEALTH CATALYST INC), valued at $25.49M, representing 1.55% of its reported portfolio and ranking #22.

Has First Light Asset Management, LLC been buying or selling HCAT?

In the latest 13F filing (Q2 2026), First Light Asset Management, LLC reduced its position in HCAT. The position peaked in Q1 2025 at 10.44M shares.

Which other funds hold HCAT?

Other major institutional holders of HCAT include CDC Financial, Inc., Palogic Value Management, L.P., Nepsis Inc., among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.